B
Bioinformatics
Market research firm supporting the analytical instrumentation and life science industries
About Bioinformatics
BioInformatics Inc. specializes in providing critical market intelligence to major suppliers in the life science, analytical instrument, and clinical diagnostic markets. The company operates primarily within the life sciences sector, offering detailed market research reports, forecasts, and data analysis to help businesses make informed decisions. BioInformatics Inc. serves a diverse clientele, including suppliers of life science consumables, cell culture products, and chromatography supplies. The company’s business model revolves around creating and selling market research reports, conducting surveys, and offering consulting services. Revenue is generated through the sale of these reports, subscriptions to their newsletters, and bespoke consulting projects. The company’s offerings include market size analysis, vendor market share, regional market breakouts, and five-year forecasts. They also provide insights into customer purchasing journeys and industry opportunities, making them a valuable resource for companies looking to navigate the complex life sciences market.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 1994
- Headquarters
- Arlington, United States
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 68.0/100
- Industry
- Marketing
- Sector
- Marketing, Market Intelligence, Agency, Branding, Consulting Services, research institute
- Client focus
- b2b
- Investment activity
- 1 company, latest Nov 2018
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Nov 2018 | $21M | $84M | BroadOak Capital Partners · Research Corporation Technologies | ↗ |
| EARLY VC✓Equity / VC | Mar 2018 | $5.2M | $21M | Undisclosed | — |
Growth signals
Latest recorded traffic for Bioinformatics is 1.2K monthly website visits, down 20% over the last three months. Bioinformatics's team declined 9.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
- BPBroadOak Capital Partners
Research Corporation Technologies
Other known investors1 additional known investor
HealthCap
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bioinformatics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bioinformatics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.